<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Polyclonal anti-thymocyte globulin (ATG) is used as an <z:chebi fb="1" ids="35705">immunosuppressive agent</z:chebi> in the treatment of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0036830" disease_type="Disease or Syndrome" abbrv="">Serum sickness</z:e> is a recognized side effect of ATG </plain></SENT>
<SENT sid="2" pm="."><plain>We observed <z:mp ids='MP_0002096'>abnormal skin</z:mp> manifestation in patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who had been treated with ATG </plain></SENT>
<SENT sid="3" pm="."><plain>We conclude that abnormal immune function caused by <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and ATG and <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> may aggravate the signs of <z:e sem="disease" ids="C0036830" disease_type="Disease or Syndrome" abbrv="">serum sickness</z:e> </plain></SENT>
</text></document>